Orient Pharma (OP), focusing on R&D and manufacturing and established on Feb 1, 2008, is the subsidiary of Orient Europharma(OEP). Located in Yunlin county in the central of Taiwan, the new pharmaceutical plant is a pharmaceutical plant of which manufacturing quality and compliance process meets extensive governmental regulations by PIC/S GMPand US FDA . Orient Pharma not only develops its own drug forms and indications, but also obtains exclusive rights to manufacture patented products from international pharmaceutical companies, and applies for drug certifications in the United States, Japan, and Europe to enhance its presence in the global market.